Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
We devised a sensitive, radioimmunoprecipitation assay (RIPA) for anti-interferon (IFN)-beta-binding antibody (BAB) detection. Our RIPA showed good agreement with a reference RIPA (mean difference, -3.2 +/- 10.6 AU), and detected BAB to both IFN-beta-1a and IFN-beta-1b. Neutralizing antibodies to IF...
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
2003
|
| _version_ | 1826280606804213760 |
|---|---|
| author | Lampasona, V Rio, J Franciotta, D Furlan, R Avolio, C Fazio, R Lavolpe, V Vincent, A Comi, G Trojano, M Montalban, X Martino, G |
| author_facet | Lampasona, V Rio, J Franciotta, D Furlan, R Avolio, C Fazio, R Lavolpe, V Vincent, A Comi, G Trojano, M Montalban, X Martino, G |
| author_sort | Lampasona, V |
| collection | OXFORD |
| description | We devised a sensitive, radioimmunoprecipitation assay (RIPA) for anti-interferon (IFN)-beta-binding antibody (BAB) detection. Our RIPA showed good agreement with a reference RIPA (mean difference, -3.2 +/- 10.6 AU), and detected BAB to both IFN-beta-1a and IFN-beta-1b. Neutralizing antibodies to IFN-b (NAB) were also determined with a standard method. BAB and NAB were measured in 393 serum samples from 77 multiple sclerosis (MS) patients treated with IFN-beta-1a or -1b, who were studied over two years, and subsequently classified as responders and non-responders. BAB were found at higher concentrations, and more frequently detected, in IFN-beta-1b- than in IFN-beta-1a-treated patients, and, at highest titres, preferentially in patients who were positive for NAB. However, in our series of MS patients, both titres and frequency of detection of BAB or NAB did not differ between IFN-b responders and non-responders. |
| first_indexed | 2024-03-07T00:16:13Z |
| format | Journal article |
| id | oxford-uuid:7aedb1d2-84b0-4d82-a9b3-5b8d36f9629b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:16:13Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:7aedb1d2-84b0-4d82-a9b3-5b8d36f9629b2022-03-26T20:47:19ZSerial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7aedb1d2-84b0-4d82-a9b3-5b8d36f9629bEnglishSymplectic Elements at Oxford2003Lampasona, VRio, JFranciotta, DFurlan, RAvolio, CFazio, RLavolpe, VVincent, AComi, GTrojano, MMontalban, XMartino, GWe devised a sensitive, radioimmunoprecipitation assay (RIPA) for anti-interferon (IFN)-beta-binding antibody (BAB) detection. Our RIPA showed good agreement with a reference RIPA (mean difference, -3.2 +/- 10.6 AU), and detected BAB to both IFN-beta-1a and IFN-beta-1b. Neutralizing antibodies to IFN-b (NAB) were also determined with a standard method. BAB and NAB were measured in 393 serum samples from 77 multiple sclerosis (MS) patients treated with IFN-beta-1a or -1b, who were studied over two years, and subsequently classified as responders and non-responders. BAB were found at higher concentrations, and more frequently detected, in IFN-beta-1b- than in IFN-beta-1a-treated patients, and, at highest titres, preferentially in patients who were positive for NAB. However, in our series of MS patients, both titres and frequency of detection of BAB or NAB did not differ between IFN-b responders and non-responders. |
| spellingShingle | Lampasona, V Rio, J Franciotta, D Furlan, R Avolio, C Fazio, R Lavolpe, V Vincent, A Comi, G Trojano, M Montalban, X Martino, G Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. |
| title | Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. |
| title_full | Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. |
| title_fullStr | Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. |
| title_full_unstemmed | Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. |
| title_short | Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. |
| title_sort | serial immunoprecipitation assays for interferon ifn beta antibodies in multiple sclerosis patients |
| work_keys_str_mv | AT lampasonav serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT rioj serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT franciottad serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT furlanr serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT avolioc serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT fazior serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT lavolpev serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT vincenta serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT comig serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT trojanom serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT montalbanx serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients AT martinog serialimmunoprecipitationassaysforinterferonifnbetaantibodiesinmultiplesclerosispatients |